What is the recommended treatment and dosage for major depressive disorder using Trazodone (antidepressant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone for Major Depressive Disorder: Treatment and Dosage Guidelines

For major depressive disorder, trazodone is recommended at an initial dosage of 150 mg/day, titrating to an effective therapeutic range of 150-300 mg/day for optimal antidepressant effect. 1

Dosing and Administration

  • Trazodone is FDA-approved for the treatment of major depressive disorder in adults 2
  • Initial dosage should be 25 mg per day, which can be gradually increased to the therapeutic range of 150-300 mg/day 3
  • For antidepressant effects, doses of 150-300 mg/day are typically required, while lower doses are often used when trazodone is prescribed as an adjunct to other antidepressants 4
  • Maximum dosage can reach 400 mg/day in divided doses, though this should be approached cautiously 3
  • Trazodone should be taken shortly after a meal or light snack to improve absorption and minimize side effects 2

Monitoring and Treatment Timeline

  • Begin assessment of patient status, therapeutic response, and adverse effects within 1-2 weeks of initiating therapy 3
  • If adequate response is not achieved within 6-8 weeks, treatment modification is strongly recommended 3
  • After achieving remission, continue treatment for 4-9 months to prevent relapse in patients with a first episode of major depressive disorder 3
  • For patients with 2 or more previous depressive episodes, longer duration of therapy (years to lifelong) may be beneficial 3

Pharmacological Profile and Mechanism of Action

  • Trazodone belongs to the SARI (Serotonin Antagonist and Reuptake Inhibitor) class of antidepressants 1
  • It has a multimodal mechanism of action, acting as an antagonist of 5-HT2A and 5-HT2C serotonin receptors, alpha1 and alpha2 adrenergic receptors, and H1 histamine receptors 5
  • At higher doses, trazodone blocks the SERT serotonin transporter, contributing to its antidepressant effect 5
  • This complex pharmacodynamic profile explains its broad therapeutic spectrum and effectiveness for various depressive symptoms 4

Clinical Advantages and Considerations

  • Trazodone is particularly effective for depression with comorbid insomnia, anxiety, and psychomotor agitation 4
  • It has a rapid onset of action compared to some other antidepressants 1
  • Trazodone has minimal anticholinergic effects and a lower risk of sexual dysfunction and weight gain compared to SSRIs 1
  • It can be used both as monotherapy at 150-300 mg/day or in combination with other antidepressants at lower doses 1

Adverse Effects and Safety Considerations

  • Common side effects include somnolence, headache, dizziness, and dry mouth 1
  • Use with caution in patients with cardiovascular disease, as it may cause orthostatic hypotension, particularly in older adults 4
  • Monitor for QT interval prolongation, especially when combined with other QT-prolonging medications 2
  • Rare but serious side effects include priapism (painful erections lasting >6 hours), which requires immediate medical attention 2
  • Trazodone may increase the risk of bleeding when used with antiplatelet agents or anticoagulants 2
  • Screen patients for bipolar disorder before initiating treatment, as trazodone may trigger manic episodes in susceptible individuals 2

Special Populations

  • In elderly patients, maximum tolerated doses are typically lower (300-400 mg/day) compared to younger adults (up to 600 mg/day) 6
  • Elderly patients may be at higher risk for orthostatic hypotension and should be monitored closely 6
  • Trazodone may be particularly useful for elderly patients with depression and insomnia 6

Formulations and Administration Tips

  • Trazodone is available in immediate-release (IR) and once-a-day (OAD) formulations 7
  • The OAD formulation maintains effective blood levels for 24 hours while avoiding concentration peaks associated with side effects 1
  • Tablets should be swallowed whole or broken in half along the score line; do not chew or crush 2
  • A gradual reduction in dosage rather than abrupt discontinuation is recommended to avoid withdrawal symptoms 2

By following these guidelines for dosing, monitoring, and addressing potential side effects, trazodone can be an effective option for treating major depressive disorder, particularly in patients with comorbid insomnia or anxiety.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.